Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models-Reference-Cited by-同舟云学术

Co-delivery of paclitaxel and cisplatin with biocompatible PLGA–PEG nanoparticles enhances chemoradiotherapy in non-small cell lung cancer models

Published:2017 Issue:30 Volume:5 Page:6049-6057
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Tian Jing¹²³⁴⁵,Min Yuanzeng⁵⁶⁷⁸⁹,Rodgers Zachary⁵⁶⁷⁸⁹^ORCID,Au Kin Man⁵⁶⁷⁸⁹,Hagan C. Tilden⁵⁶⁷⁸⁹^ORCID,Zhang Maofan⁵⁶⁷⁸⁹,Roche Kyle⁵⁶⁷⁸⁹,Yang Feifei⁵⁶⁷⁸⁹,Wagner Kyle⁵⁶⁷⁸⁹,Wang Andrew Z.⁵⁶⁷⁸⁹

Affiliation:

1. School of Biological and Environmental Engineering

2. Tianjin Vocational Institute

3. Tianjin 300410

4. P. R. China

5. Laboratory of Nano- and Translational Medicine

6. Lineberger Comprehensive Cancer Center

7. Carolina Center for Cancer Nanotechnology Excellence

8. Carolina Institute of Nanomedicine

9. University of North Carolina at Chapel Hill

Abstract

Nanoparticles co-loaded with paclitaxel and cisplatin potently enhance chemoradiotherapy in non-small cell lung cancer models versus the conventional free drug combination by delivering a precise therapeutic ratio.

Funder

National Institutes of Health

Natural Science Foundation of Tianjin City

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2017/TB/C7TB01370A

Reference42 articles.

1. L. A. Torre , R. L.Siegel and A.Jemal, in Lung Cancer and Personalized Medicine: Current Knowledge and Therapies, ed. A. Ahmad and S. Gadgeel, Springer International Publishing, Cham, 2016, pp. 1–19

2. Non-small-cell lung cancer

3. Recent Clinical Advances in Lung Cancer Management

4. New Radiotherapy and Chemoradiotherapy Approaches for Non–Small-Cell Lung Cancer

5. Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm;Heliyon;2024-04

2. Nanoencapsulation of MDM2 Inhibitor RG7388 and Class-I HDAC Inhibitor Entinostat Enhances their Therapeutic Potential Through Synergistic Antitumor Effects and Reduction of Systemic Toxicity;Molecular Pharmaceutics;2024-02-09

3. Peptide-Hydrogel Nanocomposites for Anti-Cancer Drug Delivery;Gels;2023-12-04

4. Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review;International Journal of Biological Macromolecules;2023-12

5. Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer;Journal of Functional Biomaterials;2023-09-09